HERON THERAPEUTICS, INC. /DE/ Quarterly Common Stock, Shares Authorized from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Heron Therapeutics, Inc. /De/ quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q4 2023.
  • Heron Therapeutics, Inc. /De/ Common Stock, Shares Authorized for the quarter ending December 31, 2023 was 225M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 225M 0 0% Dec 31, 2023 10-K 2024-03-12
Q4 2022 225M +75M +50% Dec 31, 2022 10-K 2024-03-12
Q4 2021 150M 0 0% Dec 31, 2021 10-K 2023-03-29
Q4 2020 150M 0 0% Dec 31, 2020 10-K 2022-02-28
Q4 2019 150M 0 0% Dec 31, 2019 10-K 2021-02-24
Q4 2018 150M 0 0% Dec 31, 2018 10-K 2020-03-02
Q4 2017 150M +150M Dec 31, 2017 10-K 2019-02-22
Q4 2016 100K* -74.9M Dec 31, 2016 10-K 2018-02-27
Q4 2015 75M 0 0% Dec 31, 2015 10-K 2017-02-23
Q4 2014 75M 0 0% Dec 31, 2014 10-K 2016-02-19
Q4 2013 75M 0 0% Dec 31, 2013 10-K 2015-03-13
Q3 2013 75M Sep 13, 2013 10-K 2016-02-19
Q4 2012 75M -1.43B -95% Dec 31, 2012 10-K 2014-03-07
Q4 2011 1.5B +1.4B +1400% Dec 31, 2011 10-K 2013-03-01
Q2 2011 1.5B Jun 30, 2011 10-Q 2013-05-10
Q4 2010 100M Dec 31, 2010 10-K 2012-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.